Acer Therapeutics Inc (NASDAQ:ACER)
| 0.8999 Delayed Data As of Jun 02 |  +0.0291 / +3.36%Today’s Change | 0.65 Today|||52-Week Range 4.56 | -64.15% Year-to-Date |
Latest ACER News | Press Releases
No recent news for Acer Therapeutics Inc.
Today’s Trading
| Previous close | 0.86 |
| Today’s open | 0.86 |
| Day’s range | 0.85 - 0.90 |
| Volume | 89,890 |
| Average volume (3 months) | 287,899 |
| Market cap | $21.7M |
Data as of 3:54pm ET, 06/02/2023
Growth & Valuation
| Earnings growth (last year) | -54.43% |
| Earnings growth (this year) | +59.04% |
| Earnings growth (next 5 years) | +10.50% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AIMAIM ImmunoTech Inc | -0.01 | -2.13% |
| ---- | ||
| ---- | ||
| COCPCocrystal Pharma Inc | -0.01 | -0.45% |
Data as of 3:59pm ET, 06/02/2023
Financials
| Next reporting date | August 15, 2023 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$26.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Newton, Massachusetts |
Forecasts
